TNF blockers get boxed warning for paediatric cancers in US
This article was originally published in Scrip
Executive Summary
The US FDA has called for the manufacturers of TNF blockers to update the boxed warnings on their labels to alert patients to an associated increased risk of lymphoma and other malignancies in children and adolescents.